A sham-controlled randomised pilot trial on baroreflex activation therapy in patients with resistant hypertension: What will the future hold?

Autor: Gordin D; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Helsinki Hypertension of Excellence, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA., Simonsen R; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland., Tikkanen I; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Helsinki Hypertension of Excellence, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland.
Jazyk: angličtina
Zdroj: Blood pressure [Blood Press] 2024 Dec; Vol. 33 (1), pp. 2417887. Date of Electronic Publication: 2024 Oct 23.
DOI: 10.1080/08037051.2024.2417887
Databáze: MEDLINE